"The safety of PCI or CABG in those with mild renal impairment is an important issue, because many patients with diabetes and multivessel disease will have mild renal dysfunction." — Michael E.

Medtronic announced it is supporting the investigator-initiated EMBRACE trial of the company’s Symplicity Spyral renal dene ...

NEW ORLEANS – Immediate complete revascularization was non-inferior to staged complete revascularization in patients who presented with acute coronary syndrome (ACS) and multivessel disease, according ...

Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN ...

SAN DIEGO, CA—Among Medicare patients with ACS undergoing CABG or PCI for multivessel CAD, surgery appears to be associated with lower mortality and fewer complications, according to a large ...

Patients with multivessel coronary artery disease undergoing CABG surgery are more likely to be alive at 1 year, and less likely to be readmitted to the hospital or require repeat revascularization ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The severity and prognosis of coronary artery disease are closely associated with treatment strategy ...

The ARTS II study was designed to determine the role of a drug-eluting stent in patients with multivessel disease and to compare its outcomes with the results observed in both arms of the ARTS I trial ...

Despite the fact that drug-eluting stents have reduced restenosis rates during percutaneous coronary intervention (PCI), their use is limited because of high costs, technological limitations of ...

Please provide your email address to receive an email when new articles are posted on . As Healio previously reported, in the main results of BEST, published in 2015 in The New England Journal of ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.